×
About 38,860 results

ALLMedicine™ Cardiomyopathy Center

Research & Reviews  14,047 results

Outcomes after heart transplantation in patients with cardiac sarcoidosis.
https://doi.org/10.1002/ehf2.13789
ESC Heart Failure; Asleh R, Briasoulis A et. al.

Jan 16th, 2022 - The number of patients with sarcoidosis requiring heart transplantation (HT) is increasing. The aim of this study was to evaluate outcomes of isolated HT in patients with sarcoid cardiomyopathy and compare them to recipients with non-ischaemic res...

Myocardial inflammation and sudden death in the inherited cardiomyopathies.
https://doi.org/10.1016/j.cjca.2022.01.004
The Canadian Journal of Cardiology; McKenna WJ, Caforio ALP

Jan 16th, 2022 - The best studied of the inherited cardiomyopathies, hypertrophic (HCM), dilated (DCM) and arrhythmogenic (ACM), present overlapping clinical phenotypes with varying, often unrecognized risk of sudden death. Risk assessment is informed by patient s...

Strength of clinical indication and therapeutic impact of the implantable cardioverter ...
https://doi.org/10.1016/j.ijcard.2022.01.022
International Journal of Cardiology; Fumagalli C, De Filippo V et. al.

Jan 16th, 2022 - The implantable cardioverter defibrillator(ICD) has revolutionized the management of patients with hypertrophic cardiomyopathy (HCM) at risk of sudden cardiac death (SCD). However, the identification of ideal candidates remains challenging. We aim...

PET Tracers for Imaging Cardiac Function in Cardio-oncology.
https://doi.org/10.1007/s11886-022-01641-4 10.1007/s12350-020-02474-w 10.1007/s12350-020-02262-6 10.1007/s12350-021-02603-z 10.1007/s12350-021-02667-x
Current Cardiology Reports; Kelly JM, Babich JW

Jan 15th, 2022 - Successful treatment of cancer can be hampered by the attendant risk of cardiotoxicity, manifesting as cardiomyopathy, left ventricle systolic dysfunction and, in some cases, heart failure. This risk can be mitigated if the injury to the heart is ...

Reaching the LVOT: You take the high road and I'll take the low.
https://doi.org/10.1111/jce.15364
Journal of Cardiovascular Electrophysiology; Powers EM, Richardson TD

Jan 15th, 2022 - The myocardium surrounding the coronary cusps is a common site of origin for ventricular arrhythmias (VA) both idiopathic and due to cardiomyopathy. The coronary cusps may also serve as a vantage point for ablation of the left ventricular summit a...

see more →

Guidelines  20 results

2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary...
https://doi.org/10.1016/j.jtcvs.2021.04.052
The Journal of Thoracic and Cardiovascular Surgery; Bakaeen FG, Gaudino M et. al.

Jul 18th, 2021 - 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure.|2021|Bakaeen FG,Gaudino M,Whitman G,Doenst T,Ruel M,|standards,diagnostic im...

2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic ca...
https://doi.org/10.1016/j.jtcvs.2021.04.001
The Journal of Thoracic and Cardiovascular Surgery; , Ommen SR et. al.

May 1st, 2021 - 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Ommen SR,Mital S...

ACR Appropriateness Criteria® Nonischemic Myocardial Disease with Clinical Manifestatio...
https://doi.org/10.1016/j.jacr.2021.01.019
Journal of the American College of Radiology : JACR; , Rajiah P et. al.

Mar 3rd, 2021 - Nonischemic cardiomyopathies encompass a broad spectrum of myocardial disorders with mechanical or electrical dysfunction without evidence of ischemia. There are five broad variants of nonischemic cardiomyopathies; hypertrophic cardiomyopathy (Var...

Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachyca...
https://doi.org/10.1016/j.jacep.2020.12.001
JACC. Clinical Electrophysiology; Elliott IA, DeJesus M et. al.

Jan 10th, 2021 - Cardiac sympathetic denervation (CSD) for refractory ventricular tachycardia (VT) has been shown to decrease VT recurrence and defibrillator shocks in patients with ischemic and nonischemic cardiomyopathy. Here and in the accompanying Video, we de...

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Ca...
https://doi.org/10.1016/j.jacc.2020.08.045
Journal of the American College of Cardiology; Ommen SR, Mital S et. al.

Nov 25th, 2020 - 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2020|Ommen SR,Mital S,B...

see more →

Drugs  62 results see all →

Clinicaltrials.gov  359 results

A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT04112290

Jan 14th, 2022 - Adult patients with hypertrophic cardiomyopathy and without known atrial fibrillation or pacemaker/implantable cardiac defibrillation will undergo implantable loop recorder implantation. No direct interventions will be performed. Prospective obser...

Magnetic Resonance Imaging:A Window to Anthracycline Toxicity
https://clinicaltrials.gov/ct2/show/NCT03211520

Jan 13th, 2022 - This is a pilot study with a descriptive study design. Anthracycline induced late onset cardiotoxicity, defined in terms of abnormal findings on echocardiography, has been reported to occur in 57% of childhood cancer survivors. Serial monitoring o...

HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT04153149

Jan 13th, 2022 - This study will evaluate the efficacy and safety of vutrisiran 25 mg administered subcutaneously (SC) once every 3 months (q3M) compared to placebo in patients with ATTR amyloidosis with cardiomyopathy.

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT05180773

Jan 13th, 2022 - The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized trial of bromocriptine therapy to evaluate its impact on myocardial recovery. All women will have an assessment of LVEF demon...

Ultra High Resolution CT to Assess Role of Intramyocardial Fat and Delayed Enhancement in Ventricular Arrhythmogenesis
https://clinicaltrials.gov/ct2/show/NCT04394637

Jan 11th, 2022 - The investigators aim to investigate the role of intramyocardial fat on ventricular arrhythmogenesis. Intramyocardial fat deposition has been frequently observed in patients with ischemic heart disease and is readily detectable by multi-detector c...

see more →

News  1,021 results

Heart Failure Imaging: Where Are We Now?
https://www.medscape.com/viewarticle/965748

Jan 7th, 2022 - Approximately 6.2 million people in the United States had heart failure (HF) between 2013 and 2016, and prevalence of the condition continues to increase over time as the population ages. Ischemic heart disease is one of the leading contributors t...

ECG Challenge: Sudden Palpitations and Shortness of Breath
https://www.medscape.com/viewarticle/965901

Jan 6th, 2022 - A 56-year-old man with a history of a reduced left ventricular ejection fraction (40%) due to a nonischemic cardiomyopathy presents to the emergency department with lightheadedness, shortness of breath, and palpitations. Physical examination is re...

Lowering Driving Restrictions After ICD Placement to 3 Months May Be Safe
https://www.medscape.com/viewarticle/965679

Dec 29th, 2021 - NEW YORK (Reuters Health) - Driving restrictions after implantable cardioverter defibrillator (ICD) placement could be safely lowered from six to three months, new research suggests. An analysis of data from more than 700 patients revealed that th...

COVID-19 Elevates Diabetes, Cardiovascular Disease Risk
https://www.medscape.com/viewarticle/965662

Dec 28th, 2021 - The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways The incidence of diabetes mellitus (DM) remains elevated for up to 1 year following COVID-19. The incidence of cardiovas...

More Promising Data on Mavacamten for Hypertropic Cardiomyopathy
https://www.medscape.com/viewarticle/964718

Dec 14th, 2021 - NEW YORK (Reuters Health) - Treatment with mavacamten improves cardiac structure and function in patients with obstructive hypertropic cardiomyopathy (HCM), according to echocardiographic findings from the EXPLORER-HCM study. "This analysis of EXP...

see more →

Patient Education  35 results see all →